Publication of the WHO list of priority medical devices for cardiovascular disease and diabetes
The WHO List of Priority Medical Devices for the Management of Cardiovascular Disease and Diabetes, released today, will help policymakers and healthcare providers prioritize the selection and procurement of medical devices for these conditions. health. It includes more than 500 devices needed at all levels of the healthcare system, from primary care facilities to highly specialized hospitals, and devices needed for health emergencies such as cardiac arrests, strokes, and hypo or hyperglycemic emergencies.
The new list provides clinical guidelines for specific conditions, describes relevant interventions required (e.g. hospitalization, cardiac surgery, intensive care, laboratory tests, and medical imaging) and then lists all required medical equipment such as sets of surgical instruments, personal protective equipment, and diagnostic and treatment devices.
The ultimate goal of this new list is to help healthcare providers implement essential interventions for the detection and management of heart disease and diabetes across the continuum of care, thereby reducing the number of hospitalizations and deaths and save valuable health resources.
Noncommunicable diseases (NCDs) – which include cardiovascular disease and diabetes – account for 74% of annual deaths worldwide and are responsible for more than 15 million people who die prematurely each year between the ages of 30 and 69. Low- and middle-income countries bear 85% of the burden of these premature deaths, largely because they lack the testing and surveillance equipment needed to screen, diagnose and treat NCDs.
Along with the List, WHO has developed MeDevIS, a medical device information system and clearinghouse where biomedical engineers, policy makers and hospital managers can find more information on devices. specific medical devices, their use and how to maintain them. The site currently lists 1,500 devices and will continue to be updated for other illnesses and health issues.
The list released today is one in a series of lists prioritizing devices for high-burden diseases, including cancer and COVID-19. These lists are based on the best available evidence on the essential medical devices countries need to prevent, diagnose and treat disease. They should be adapted to national contexts and used to update or expand national lists. Ultimately, the lists are intended to help countries increase the availability and appropriate use of medical devices and promote access to better quality health services.
The full set of lists is the global benchmark for countries to develop or update their national lists for procurement and reimbursement of disease screening, diagnosis and treatment devices. They also help them ensure value for money and ultimately increase access.